JANUARY-FEBRUARY1CHEMICAL INDUSTRY REVIEWCHEMICALINDUSTRYREVIEW.COMTHREE C'S TO ENABLE CONTINUOUS DEVELOPMENT AND MANUFACTURING FOR SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENTISSN 2837-2921 JANUARY-FEBRUARY 2026Nick Thomson, Senior Director, Chemical Research and Development, Pfizer Inc [NYSE: PFE]
Page 2 >